Efficacy of early (48 and 96 hour) protection against feline viral rhinotracheitis following intranasal vaccination with a live temperature sensitive mutant.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to C J Gaskell.
Explore the source record for details and available documents.
Three naturally occurring cases of cowpox virus infection in the domestic cat are described. Isolate L97 was identified as cowpox virus on the basis of morphology, serology and characteristic cytopathic effect in tissue culture and on the chorioallantoic membrane of embryonated eggs. All three cases showed multiple skin lesions, slight conjunctivitis or purulent ocular discharge but there were no respiratory signs. Two animals recovered, the third was put down as a stray. The disease was reproduced in experimental cats. Isolate L97 was inoculated into two cats intravenously and two cats by skin scarification. All four developed skin lesions at the site or sites of inoculation, and in one cat multiple lesions developed. The two intravenously inoculated animals also developed severe oedema of the neck and brisket around the site of inoculation into the jugular vein, and one cat died. Serological and pathological findings on both the natural and experimental infections are described. Serum neutralising antibody titres in both natural and experimental early convalescent cases were significantly enhanced by the addition of complement.
Biopsy or post mortem specimens from the thyroid glands of 7 dogs with clinical hypothyroidism were examined histologically. Six of the 7 cases were diagnosed histologically as lymphocytic thyroiditis which is characterized by widespread destruction and replacement of the gland by an infiltrate of lymphocytes, plasma cells and macrophages. The 7th case was characterized by fibrosis, with minimal inflammatory cell infiltration and might represent an end stage of lymphocytic thyroiditis. Five of the 7 dogs were female and 4 of these animals had shown clinical signs since 2 years of age. Comparisons are made with a previous report of functional lymphocytic thyroiditis in the pet dog and with similar conditions in man and an obese strain of White Leghorn poultry.
Ascites and acquired portosystemic shunts were consistent findings in six dogs with a chronic hepatitis of unusual morphology and unknown etiology. The hepatitis was characterized by a mixed inflammatory infiltrate and dissection of the lobular parenchyma by reticulin and fine collagen fibers. While limiting plates were disrupted by this process, portal inflammation was inconstant and seldom marked. Biopsy samples generally had very small, sublobular regenerative nodules, but larger nodules sometimes were present postmortem. Dilated vascular channels, representing sinusoids and portal venous radicles were a prominent feature of most affected livers. The lesions differ from previously documented chronic hepatitis in the dog, and from the chronic hepatitides in man.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The efficacy of an inactivated vaccine derived from feline calicivirus (FCV) strain FS2 was assessed against challenge with three UK field strains of FCV. The mean clinical score, calculated on the number of signs recorded per day over 21 days after challenge, was lower for vaccinated cats when compared to unvaccinated animals though the difference was not statistically significant. All cats excreted FCV throughout the three weeks following challenge and there was no difference in the number of days of virus shedding during this period between vaccinated and unvaccinated animals. The development of FCV serum neutralising antibody titres following vaccination and challenge was recorded. In the second part of the study the ability of vaccinated and challenged cats to become FCV carriers and then infect susceptible in-contact animals was demonstrated.
Eight cats were vaccinated intranasally with a combined feline calicivirus/feline viral rhinotracheitis (FVR) virus commercial vaccine. Following intranasal challenge with a field strain of FVR virus and subsequent treatment with corticosteroid, no virus was recovered from any of the eight cats, while FVR virus was recovered following corticosteroid treatment from two of four unvaccinated and challenged controls. No evidence was found for the development of an FVR virus carrier state with the intranasal vaccine virus.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The clinical and radiological features of 30 cases of anterior mediastinal lymphosarcoma in the cat are described; they represented 48 per cent of all cases of lymphosarcoma recorded at the University of Bristol Veterinary School between 1972 and 1977. The condition principally affected young cats and there was a predisposition in oriental breeds. Dyspnoea and regurgitation were the two most common major presenting signs. Diagnosis was made in most cases on the basis of radiological examination, but in some cytological examination of the thoracic fluid was necessary for confirmation.
Explore the source record for details and available documents.
Clinical signs in three young dogs with primary lung neoplasms included cough, weight loss and anorexia. Chest radiographs taken in the terminal stages of the disease showed nodular and diffuse consolidation of the lungs typical of primary neoplasms. Macroscopically the lungs were infiltrated by firm, pale tissue; similar tissue replaced the enlarged bronchial lymph nodes. In two dogs similar deposits were found also in the liver and spleen. The infiltrates were composed of atypical, polymorphous lymphoreticular cells. Invasion of pulmonary blood vessels and of bronchi and bronchioles was striking. The lesions closely resembled those of lymphomatoid granulomatosis, a rare human disease of unknown cause.
The effect of field feline viral rhinotracheitis (FVR) virus challenge on cats previously vaccinated with a combined FVR/feline calicivirus intramuscular vaccine was studied in relation to the development of an FVR carrier state. There was no virus shedding of either of the two vaccine viruses following vaccination. Treatment with corticosteroid 60 days after vaccination and before challenge with FVR virus did not induce virus re-excretion in vaccinates or controls; neither did similar treatment induce shedding 63 days after challenge of both vaccinates and controls with virulent field virus. After a further 55 days however, FVR virus shedding was elicited in one of four previously vaccinated and challenged cats compared with two of four unvaccinated and challenged controls. Two sentinel cats remained virologically and serologically free of FVR throughout. The vaccine was shown to be effective in controlling the disease; 12 weeks after initial vaccination no clinical signs were seen in three of four cats following intranasal challenge with 10(5)CCID50 of virulent field FVR virus, and a mild transient unilateral ocular and nasal discharge was seen in the remaining cat for one day only. Severe clinical signs of approximately 10 days' duration were seen in all four unvaccinated challenged controls. The virological and serological responses of the cats were also recorded.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.